Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Country | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|
| KE | KIMBALL ELECTRONICS INC | United States | $517.78M | 24,869,206 | 75.85% | 6.39% | Net Selling | |
| REPL | REPLIMUNE GROUP INC | United States | $394.11M | 61,387,786 | 67.71% | 32.29% | Net Selling | |
| CRGY | CRESCENT ENERGY CO | United States | $1.95B | 179,656,924 | 32.21% | 27.21% | Net Selling | Net Selling |
| RANI | RANI THERAPEUTICS HOLDINGS INC | United States | $335.05M | 50,157,292 | 5.88% | 51.66% | Net Buying | |
| STNG | SCORPIO TANKERS INC | Monaco | $3.86B | 53,107,765 | 56.90% | 0.00% | ||
| VIPS | VIPSHOP HOLDINGS LTD | China | $8.53B | 108,460,605 | 100.00% | 0.00% | ||
| ENGN | ENGENE HOLDINGS INC | Canada | $675.51M | 43,581,331 | 32.55% | 27.91% | Net Buying | Net Buying |
| FOUR | SHIFT4 PAYMENTS INC | United States | $5.09B | 86,191,714 | 68.55% | 3.85% | Net Selling | Net Selling |
| APTO | APTOSE BIOSCIENCES INC | Canada | $19.18M | 15,717,701 | 7.58% | 67.78% | Net Buying | |
| ADVM | ADVERUM BIOTECHNOLOGIES INC | United States | $190.74M | 20,754,915 | 72.30% | 27.70% | Net Buying | Net Buying |
| NOTE | FISCALNOTE HOLDINGS INC | United States | $179.48M | 131,009,719 | 35.02% | 64.98% | Net Selling | Net Selling |
| HTBK | HERITAGE COMMERCE CORP | United States | $489.36M | 61,169,473 | 73.09% | 22.11% | Net Buying | Net Selling |
| GOSS | GOSSAMER BIO INC | United States | $150.69M | 225,582,250 | 86.47% | 13.53% | Net Buying | Net Selling |
| EWTX | EDGEWISE THERAPEUTICS INC | United States | $1.51B | 93,110,623 | 84.23% | 15.77% | Net Buying | Net Buying |
| VLRS | CONTROLADORA VUELA COMPANIA DE AVIACION SAB DE CV | Mexico | $955.49M | 1,108,462,804 | 4.14% | 0.00% | ||
| ANRO | ALTO NEUROSCIENCE INC | United States | $381.21M | 26,883,988 | 0.00% | 24.97% | Net Buying | Net Buying |
| MGM | MGM RESORTS INTERNATIONAL | United States | $13.14B | 319,678,271 | 37.96% | 62.04% | Net Selling | Net Selling |
| LPTX | LEAP THERAPEUTICS INC | United States | $83.20M | 25,600,137 | 12.25% | 87.75% | ||
| RGTI | RIGETTI COMPUTING INC | United States | $201.78M | 158,881,022 | 32.41% | 24.40% | Net Selling | Net Selling |
| NUVL | NUVALENT INC | United States | $4.28B | 64,067,638 | 70.71% | 29.29% | Net Selling | Net Selling |
| TNYA | TENAYA THERAPEUTICS INC | United States | $338.40M | 78,516,142 | 55.16% | 44.84% | Net Buying | Net Buying |
| RCUS | ARCUS BIOSCIENCES INC | United States | $1.41B | 90,864,829 | 48.32% | 51.68% | Net Buying | Net Buying |
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS INC | United States | $83.48M | 27,918,560 | 18.78% | 38.25% | ||
| PMVP | PMV PHARMACEUTICALS INC | United States | $90.03M | 51,443,488 | 62.78% | 37.22% | Net Buying | |
| ABUS | ARBUTUS BIOPHARMA CORP | Canada | $490.01M | 179,492,199 | 24.75% | 75.25% | Net Selling | Net Selling |
| HLVX | HILLEVAX INC | United States | $635.67M | 49,700,828 | 65.85% | 34.15% | Net Selling | Net Selling |
| DNLI | DENALI THERAPEUTICS INC | United States | $2.15B | 139,160,239 | 56.52% | 43.48% | Net Selling | Net Selling |
| AMRX | AMNEAL PHARMACEUTICALS INC | $1.80B | 307,006,908 | 25.23% | 74.77% | Net Selling | Net Selling | |
| BIP | BROOKFIELD INFRASTRUCTURE PARTNERS LP | Bermuda | $12.52B | 461,343,972 | 57.49% | 0.00% | ||
| NR | NEWPARK RESOURCES INC | United States | $619.42M | 85,201,652 | 80.86% | 12.01% | Net Selling | |
| DYN | DYNE THERAPEUTICS INC | United States | $2.03B | 81,958,068 | 65.80% | 34.20% | Net Selling | Net Selling |
| DRTS | ALPHA TAU MEDICAL LTD | Israel | $167.56M | 69,670,612 | 2.64% | 0.00% | ||
| DAL | DELTA AIR LINES INC | United States | $32.21B | 645,312,283 | 69.12% | 0.38% | Net Selling | Net Selling |
| NE | NOBLE CORP PLC | United States | $6.61B | 142,766,794 | 68.01% | 9.87% | Net Selling | Net Selling |
| SYNA | SYNAPTICS INC | United States | $3.51B | 39,303,612 | 93.47% | 5.04% | Net Selling | Net Selling |
| MGX | METAGENOMI INC | United States | $282.17M | 37,472,351 | 0.00% | 32.96% | Net Buying | Net Buying |
| ACET | ADICET BIO INC | United States | $138.02M | 82,153,984 | 40.62% | 19.50% | Net Buying | |
| NUVB | NUVATION BIO INC | United States | $587.04M | 219,046,219 | 50.10% | 49.90% | Net Buying | |
| OPK | OPKO HEALTH INC | United States | $878.21M | 696,991,667 | 17.43% | 82.57% | Net Buying | Net Buying |
| XENE | XENON PHARMACEUTICALS INC | Canada | $3.06B | 75,432,482 | 95.45% | 3.29% | Net Selling | Net Selling |
| KMPR | KEMPER CORP | United States | $3.69B | 64,323,693 | 62.87% | 37.13% | Net Buying | Net Selling |
| ATXS | ASTRIA THERAPEUTICS INC | United States | $494.13M | 54,903,061 | 67.13% | 25.09% | Net Buying | Net Buying |
| CUTR | CUTERA INC | United States | $42.32M | 19,960,622 | 71.44% | 28.56% | Net Buying | Net Selling |
| BWEN | BROADWIND INC | United States | $47.01M | 21,566,364 | 7.84% | 92.16% | Net Selling | |
| RCKT | ROCKET PHARMACEUTICALS INC | United States | $1.99B | 90,504,248 | 54.89% | 45.11% | Net Selling | Net Selling |
| PRTS | CARPARTSCOM INC | United States | $68.48M | 56,597,483 | 42.58% | 57.42% | Net Selling | Net Selling |
| LXEO | LEXEO THERAPEUTICS INC | United States | $333.36M | 26,668,956 | 60.65% | 25.62% | Net Buying | |
| NDLS | NOODLES & CO | United States | $62.99M | 44,989,714 | 47.77% | 52.23% | Net Buying | Net Selling |
| ZUO | ZUORA INC | United States | $1.45B | 145,999,999 | 73.73% | 5.72% | Net Selling | Net Selling |
| PRGO | PERRIGO CO PLC | Ireland | $4.33B | 135,515,939 | 61.54% | 38.46% | Net Selling | Net Buying |
| MBRX | MOLECULIN BIOTECH INC | United States | $10.31M | 2,227,516 | 45.78% | 54.22% | Net Buying | |
| AEYE | AUDIOEYE INC | United States | $167.13M | 11,695,373 | 7.23% | 86.13% | Net Buying | Net Selling |
| ATNM | ACTINIUM PHARMACEUTICALS INC | United States | $204.61M | 29,783,451 | 15.63% | 84.37% | ||
| CRGX | CARGO THERAPEUTICS INC | United States | $735.30M | 39,363,052 | 71.34% | 28.66% | Net Buying | |
| CLDX | CELLDEX THERAPEUTICS INC | United States | $2.03B | 55,900,679 | 82.75% | 17.25% | Net Buying | Net Buying |
| PYXS | PYXIS ONCOLOGY INC | United States | $249.97M | 58,133,375 | 15.13% | 36.17% | Net Selling | |
| PINE | ALPINE INCOME PROPERTY TRUST INC | United States | $203.39M | 13,623,239 | 56.52% | 8.92% | Net Buying | Net Buying |
| RZLT | REZOLUTE INC | United States | $105.40M | 39,625,271 | 21.83% | 78.17% | Net Buying | Net Buying |
| PDSB | PDS BIOTECHNOLOGY CORP | United States | $119.94M | 36,679,275 | 22.71% | 31.97% | ||
| LW | LAMB WESTON HOLDINGS INC | United States | $12.11B | 144,391,021 | 89.18% | 1.05% | Net Selling | Net Buying |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | United States | $2.71B | 63,886,757 | 72.47% | 27.53% | Net Buying | Net Selling |
| NTES | NETEASE INC | China | $61.64B | 3,210,783,141 | 2.22% | 0.00% | ||
| MAG | MAG SILVER CORP | Canada | $1.33B | 102,972,650 | 38.42% | 0.00% | ||
| UNCY | UNICYCIVE THERAPEUTICS INC | United States | $35.80M | 34,756,436 | 37.49% | 18.00% | ||
| LBTYA | LIBERTY GLOBAL LTD | United Kingdom | $6.17B | 377,546,627 | 82.91% | 13.82% | Net Selling | Net Selling |
| ASTS | AST SPACEMOBILE INC | United States | $570.98M | 256,042,836 | 13.46% | 45.53% | Net Selling | Net Selling |
| CAR | AVIS BUDGET GROUP INC | United States | $3.57B | 35,472,745 | 33.29% | 66.71% | Net Selling | Net Selling |
| STRO | SUTRO BIOPHARMA INC | United States | $213.55M | 62,441,963 | 78.85% | 21.15% | Net Selling | Net Selling |
| AVBP | ARRIVENT BIOPHARMA INC | United States | $471.97M | 30,567,768 | 0.00% | 34.25% | Net Buying | Net Buying |
| CRH | CRH PUBLIC LTD CO | Ireland | $54.23B | 690,357,372 | 62.43% | 0.00% | ||
| ACLX | ARCELLX INC | United States | $2.74B | 52,796,618 | 44.19% | 55.81% | Net Selling | Net Selling |
| EYPT | EYEPOINT PHARMACEUTICALS INC | United States | $834.67M | 49,830,792 | 20.11% | 79.89% | Net Selling | Net Buying |
| TRML | TOURMALINE BIO INC | United States | $402.14M | 25,646,509 | 43.00% | 57.00% | Net Selling | Net Buying |
| DCO | DUCOMMUN INC | United States | $789.74M | 14,641,154 | 86.85% | 9.96% | Net Selling | Net Selling |
| ANNX | ANNEXON INC | United States | $423.12M | 90,025,573 | 76.31% | 23.69% | Net Buying | Net Selling |
| FSBC | FIVE STAR BANCORP | United States | $377.44M | 17,353,369 | 46.05% | 49.88% | Net Buying | Net Buying |
| CMPS | COMPASS PATHWAYS PLC | United Kingdom | $509.97M | 64,227,371 | 35.78% | 53.62% | Net Selling | Net Selling |
| KC | KINGSOFT CLOUD HOLDINGS LTD | China | $754.17M | 3,562,097,466 | 0.95% | 0.00% | ||
| MXCT | MAXCYTE INC | United States | $386.32M | 104,128,650 | 62.67% | 11.15% | Net Buying | Net Buying |
| CZR | CAESARS ENTERTAINMENT INC | United States | $7.92B | 216,299,768 | 78.37% | 21.63% | Net Selling | Net Selling |
| DFLI | DRAGONFLY ENERGY HOLDINGS CORP | United States | $46.34M | 60,260,282 | 8.09% | 72.63% | ||
| TNK | TEEKAY TANKERS LTD | Bermuda | $2.00B | 34,093,108 | 52.29% | 0.00% | ||
| CNOB | CONNECTONE BANCORP INC | United States | $702.79M | 38,404,043 | 60.01% | 39.99% | Net Selling | Net Selling |
| INAB | IN8BIO INC | United States | $45.02M | 43,287,325 | 19.83% | 52.04% | Net Buying | |
| PRGS | PROGRESS SOFTWARE CORP | United States | $2.18B | 43,218,086 | 83.38% | 16.62% | Net Selling | Net Selling |
| SLNO | SOLENO THERAPEUTICS INC | United States | $1.23B | 32,460,579 | 20.62% | 79.38% | Net Buying | Net Selling |
| VSTM | VERASTEM INC | United States | $237.27M | 25,295,495 | 25.42% | 74.58% | Net Selling | Net Selling |
| MNMD | MIND MEDICINE (MINDMED) INC | Canada | $352.17M | 41,334,307 | 10.01% | 89.99% | Net Selling | Net Selling |
| GPRE | GREEN PLAINS INC | United States | $1.38B | 64,264,356 | 54.71% | 45.29% | Net Buying | Net Buying |
| LENZ | LENZ THERAPEUTICS INC | United States | $130.78M | 8,319,561 | 49.99% | 50.01% | Net Buying | Net Buying |
| TSHA | TAYSHA GENE THERAPIES INC | United States | $446.97M | 187,018,275 | 69.58% | 15.93% | Net Buying | Net Selling |
| XNCR | XENCOR INC | United States | $1.22B | 61,120,272 | 66.74% | 33.26% | Net Buying | Net Selling |
| TCRX | TSCAN THERAPEUTICS INC | United States | $350.50M | 47,882,196 | 66.65% | 29.73% | Net Buying | |
| NAMS | NEWAMSTERDAM PHARMA CO NV | Netherlands | $1.96B | 89,266,673 | 60.05% | 39.95% | Net Selling | Net Selling |
| OTLK | OUTLOOK THERAPEUTICS INC | United States | $109.70M | 13,012,876 | 13.26% | 86.74% | Net Buying | Net Buying |
| MRVI | MARAVAI LIFESCIENCES HOLDINGS INC | United States | $1.94B | 251,399,871 | 35.06% | 64.94% | Net Selling | Net Selling |
| CRMD | CORMEDIX INC | United States | $291.95M | 54,981,102 | 34.05% | 10.98% | Net Buying | Net Buying |
| SLN | SILENCE THERAPEUTICS PLC | United Kingdom | $855.04M | 118,846,966 | 17.28% | 0.00% | ||
| DBRG | DIGITALBRIDGE GROUP INC | United States | $2.74B | 163,469,517 | 88.56% | 11.44% | Net Selling | Net Selling |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.